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IL-2, the lymphocytotrophic hormone responsible for T cell cycle progression,
initiates its effects by interacting with high-affinity, IL-2-specific membrane
receptors (reviewed in 1) . The development of the radiolabeled IL-2 binding
assay (2) was a crucial step in the identification and characterization of IL-2-R,
as it made possible the detection of mAbs that compete with IL-2 for binding
(3-5) . These antibodies (termed anti-Tac) subsequently proved instrumental in
experimental approaches that ultimately led to the isolation of cDNA clones
encoding a 28,500 M,. protein containing sites reactive with both IL-2 and anti-
Tac (Tac cDNA) (6, 7) . However, more recently anti-Tac and the IL-2 binding
assay led to still further experiments uncovering a second class of binding sites
with a much lower affinity for IL-2 than the high-affinity receptors described
originally (i . e ., K,, = 10 nM vs 10 pM ; references 8, 9) . In the light of these and
subsequent experiments some uncertainty has evolved regarding the structural
nature of biologically relevant high-affinity IL-2-R vs . low-affinity IL-2 binding
sites . Seeking further data on both types of IL-2 binding, we have examined a
neoplastic T cell line established originally from a patient with T cell acute
lymphoblastic leukemia (T-ALL)' (10) . This cell line, designated YT, attracted
our attention because the low levels of Tac antigen that it expresses can be
augmented considerably by treatment with conditioned medium, i . e ., culture
supernatants of cell lines derived from patients with adultT cell leukemia (ATL)
(10, 11) .
Here we report that YT cells express novel IL-2 binding sites, completely
separate and distinguishable from the sites described previously (8, 9) . Clones of
YT cells that exclusively express this new variety of receptor do not contain
mRNA detectable by hybridization with radiolabeled Tac cDNA, nor do they
express cell surface Tac antigen . Moreover, these newly recognized sites bind
IL-2 with a distinctive affinity, intermediate by comparison with previously
identified characteristic high-affinity IL-2-R and low-affinity binding sites .
These findings indicated that an entirely separate gene encodes these curious
IL-2-R, and prompted a reevaluation of the structural basis for high-affinity vs .
low-affinity IL-2 binding . Using radioiodinated IL-2 and chemical crosslinking
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approaches, the newly recognized IL-2 binding protein was found to be 75,000
M,_, readily distinguishable from the Tac antigen protein (M,_ 55,000). Remarka-
bly enough, the expression of high-affinity IL-2-R by both YT cells and normal
activated T cells correlated with the simultaneous expression of Tac antigen and
this novel IL-2 binding site. Consequently, we propose that high-affinity IL-2-R
are made up of these two IL-2 binding proteins, which cooperate to form




Human leukemic cell lines YT (10), JURKAT clone 6.8 (2), HUT-102
(12), and ATL-2 (13) were cultured in RPMI 1640 medium (Gibco Laboratories, Grand
Island, NY) supplemented with 10% heat-inactivated FCS (56°C, 30 min, Sterile Systems,
Inc., Logan, UT) 50 U/ml penicillin, 50,ug/ml gentamicin, and 300 ,ug/ml L-glutamine
in a humidified atmosphere of 5% CO, in air. ATL-conditioned medium was prepared
by culturing ATL-2 cells at 3 X 10`' cells/ml for 48 h . After removing the cells by
centrifugation (1,000 X g, 10 min), the supernatants were filtered (0.2 Am) and stored at
4 °C before use. Individual lots of conditioned medium were standardized by titration
with YT cells, and were adjusted so that 20% conditioned medium yielded maximum
enhancement of Tac antigen expression within 24 h.
Activated human T cells were prepared by stimulating PBMC with anti-T3 (Ortho
Pharmaceutical, Raritan, NJ) for 3 d. For some experiments these cellswere then cultured
for an additional 10 d with 125 pM IL-2. To ensure maximal expression of both high-
affinity and low-affinity IL-2 binding sites by these 13-d synchronized (G/G,) cell
populations, phorbol-12, 13-dibutyrate (Pdbu, 50 ng/ml; Consolidated Midland Corp.,
Brewster, NY) was provided during the first 6 h, followed by incubation with IL-2 (125
pM) for 18 h as described previously (14).
Radiolabeled IL-2 and Anti-Tac Binding Assays.
￿
Homogeneous rIL-2 (15) was provided
by Takeda Chemical Industries, Ltd., Osaka, Japan as a 1 .0 mg/ml solution in ammonium
acetate buffer, pH 5.0. mAbs reactive with the Tac epitope were made available by Dr.
Ellis Reinherz (1HT4; IgG2a; Dana-Farber Cancer Center, Boston, MA). IL-2 and anti-
Tac were radioiodinated using lactoperoxidase/glucose oxidase (Enzymobeads; Bio-Rad
Laboratories, Richmond, CA) according to the manufacturer's instructions. The specific
activity ofanti-Tac was 5.3 X 10' cpm/pmol. Radioiodinated IL-2 was prepared with two
different specific activities (1 .0 X 10' cpm/pmol and 1 .0 X 10' cpm/pmol) so that binding
assays couldbe carried out at IL-2 concentrations ranging from 1 pM to 100 nM. Binding
of both ligands to whole cells was performed as described previously (2), except that the
radioiodinated ligands were incubated together with the cell suspension (10' cells in 0.2
ml RPMI 1640 medium supplemented with 10% FCS), overlayed onto a 0.2 ml mixture
of 80% silicone oil (Dexter Hysol 550 fluid; Dexter Corp., Orlean, NY) and 20% paraffin
oil (0-119; Fischer Scientific Co., Pittsburgh, PA). After a 20-min incubation at 37°C,
the tubes were centrifuged (8,500 g for 90 s), the tips of the tubes containing the cell
pellet were severed, and the cell-bound and free radioactivity were determined by solid
scintillation counting. The calculated values for the number ofbinding sites per cell were
derived by Scatchard analysis of equilibrium binding data after subtraction of nonspecific
binding determined in the presence of 150-fold molar excess of unlabeled ligand. The
lower limit of detection for both ligands was 50 binding sites per cell.
Flow Cytofluorometry. 10' cells/ml were incubated (45 min, 4°C) with a saturating
concentration of anti-Tac (100 nM), washed three times, and then incubated with a 1 :20
dilution of fluorescein-conjugated F(ab')1 fragments of rabbit anti-mouse Ig (Dakopatts;
Accurate Chemical & Scientific Corp., Westbury, NY). Samples were passed through a
cytofluorograph (system 50H; Ortho Diagnostic Systems, Inc., Westwood MA) using an
argon ion laserat 488 nm excitation wavelength. Green fluorescence was observed using
a 630-nm long-pass filter. A minimum of 10' cells, gated to exclude nonviable cells, were
accumulated for each histogram. All data were analyzed using the 2.150 Data HandlerTESHIGAWARA ET AL.
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System (Ortho Diagnostics Systems, Inc.), and the percentage of positive cells was calcu-
lated against a background of nonspecific labeling with normal mouse Ig (1-3%).
cDNA/RNA Hybridization.
￿
Total RNA was isolated from cells by solubilization in 6.0
M guanidine hydrochloride, 20 mM sodium acetate (pH 5 .0), followed by ultracentrifu-
gation through a 5.7 M cesium chloride cushion (16). Poly(A)+ RNA was prepared by
oligo(dT) affinity column chromatography as described previously (17). Serial twofold
dilutions of RNA (10 ug) were applied to nitrocellulose filters (Schleicher & Schuell, Inc.,
Keene, NH) using a dot-blot apparatus (Bethesda Research Laboratories, Bethesda, MD).
The filters were baked at reduced pressure for 2 h at 80 °C and were prehybridized
overnight at 42°C with 6X SSC (1X SSC: 0.15 M sodium chloride, 15 mM sodium citrate,
pH 7 .0) containing 1 % SDS, poly adenosine (50 /Ag/ml), sheared salmon sperm DNA (100
,ug/ml) and 1X Denhardt's solution. Hybridization was effected at 40 °C for 24 h in 50%
deionized formamide, 6X SSC, 0 .1% SDS with 100 ng'''P-nick-translated probes (1-2 X
10" CPM/Ag DNA) from Tac cDNA (7) and HLA-B7 cDNA (18). After high stringency
washes with 0.1 X SSC, 0.1 % SDS (30 min, 20'C; 30 min, 56'C), radioactivity bound to
the filters was detected by autoradiography. Hybridization intensity was quantified by
densitometry.
Gel Electrophoresis ofIL-2-binding Proteins.
￿
Radioiodinated IL-2 was crosslinked to IL-
2 binding proteins according to the following protocol: YT cells (20 X 10' cells/ml) were
incubated with 10 nM '''I-IL-2 for 1 h at 4 °C, then treated with 1 .0 mM disuccinimidyl
suberate (DSS) (19) in HBSS. After washing with HBSS, the cells were disrupted using a
Dounce homogenizer and the nuclear-free lysate was enriched for plasma membranes as
described previously (20). This membrane fraction was solubilized using 1 % sodium
deoxycholate, 10 mM Tris-HCI (pH 7.4), 0.15 M NaCl, 1 mM PMSF, then clarified by
centrifugation (100,000 g, 60 min). The supernatant was electrophoresed using a 7.5%
acrylamide gel under reducing conditions (20 mM DTT). Similar conditions were used
for normal activated T cells, except that 10' cells were exposed to
125I-IL-2 concentrations
of 4 nM and 50 pM . After crosslinking with DSS, membrane proteins were solubilized
with 0 .5% NP-40 before electrophoresis under reducing conditions on a 7-15% acryl-
amide gradient gel.
For immunoprecipitation of YT cell membrane proteins, the cells were iodinated using
lactoperoxidase as described (21), then radiolabeled proteins were extracted with a lysis
buffer (RIPA: 10 mM Tris-HCI, pH 7.4, 0.15 M NaCl, 1 mM PMSF) containing 1%
Triton X-100. Proteins were precipitated with anti-Tac (100 nM) and formalin-fixed
Staphylococcus aureus Cowan I cells, and electrophoresed under reducing conditions on a
7 .5% acrylamide gel.
Results
The Effect of ATL-conditioned Medium on YT Cell IL-2 Receptor Expres-
sion. Previous experiments had already established that ATL-conditioned me-
dium contained an activity that augmented the expression of the Tac antigen
(11), but the nature of the IL-2-R expressed by YT cells remained unexplored,
particularly as regards the affinity of their IL-2 binding. Accordingly, YT cells
were exposed to ATL-conditioned medium for 24 h, after which IL-2-R expres-
sion was assessed with radiolabeled IL-2 binding assays and anti-Tac immunocy-
tofluorography. As shown in Fig. 1, ATL-conditioned medium promoted a
sixfold increase in Tac antigen expression (Fig. 1, A and C). By comparison, as
displayed by Scatchard plots (Fig. 1, B and D), the number of high-affinity IL-2-
R was augmented to a similar degree by the ATL-derived conditioned medium
(1,120 sites per cell to 7880 sites per cell), but the number of IL-2 binding sites
with lower affinity remained unchanged (32,200 sites per cell vs. 33,300 sites
per cell). These results pointed to the activity contained within ATL-conditioned
medium as promoting selectively the expression of high-affinity IL-2-R that also226
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FIGURE 1 . The effect of ATL-conditioned medium on YT cell Tac antigen and 11-2-R
expression . (A) Conth-ol YT cell Tac antigen expression as detected by inununocytofluorogra-
phy with anti-Tac. A MFI indicates the mean fluorescence intensity, after subtraction of the
MFI obtained using control Ig (20.0 U). (B) Scatchard plot of '15I-IL-2 binding to control YT
cells. ((:) Anti=Tac innnunocytofluorogr<IThy of YT cells exposed to 20% ATI.-conditioned
medium fen- 24 h. (D) Scatchard plot of °I-IL-2 binding to an aliquot of the cells exposed to
20% ATI .conditioned medium .
bear the Tac epitope. However, the data also suggested that YT cells express
sites with a lower IL-2-binding affinity that do not contain the Tac epitope, and
that do not increase upon exposure to ATL-conditioned medium.
IL-2-R Expressed by YT Cell Clones.
￿
To define further the types of IL-2-R
expressed by YT cells, the YT cell line was cloned by limiting dilution (<_0.3 cell
per well) (22). Of nine clones isolated, five resembled the original YT cell line,
in that they expressed both high and lower affinity IL-2 binding sites; here too,
the ATL-conditioned medium enhanced only the number ofhigh-affinity IL-2-
R. By comparison, four of the nine clones differed from the others, in that no
high-affinity IL-2-R expression could be discerned. Moreover, the lower affinity
IL-2 binding sites expressed by these clones contained no Tac epitopes, as
monitored using either immunocytofluorography or radioiodinated anti-Tac
binding. Furthermore, as displayed by the Scatchard plots in Fig. 2 for a
representative clone (2C2), there was no response discernible to ATL-derived
conditioned medium monitored by radiolabeled IL-2 binding. Analysis of IL-2
binding to clone 2C2 cells revealed still another perplexing characteristic of
these binding sites; the K,, was found consistently to be 1.5 ± 0.17 nM (mean ±
SEM; n = 9), clearly different from high-affinity IL-2-R, but also distinguishable
from low-affinity IL-2 binding sites expressed by normal T cells and ATL cell
lines. For illustration and comparison, the data from a representative IL-2
binding experiment performed with normal T cells are also plotted in Fig. 2. As
the slopes of the data points are indicative of the binding affinities, it can be
readily discerned that normal T cells bind IL-2 with two distinct affinities (K,, =
10.6 pM, 1,700 sites per cell; K,, = 10.0 nM, 13,000 sites per cell), whereas the
YT clone 2C2 cells bind IL-2 with a single intermediate affinity (K,, = 1.7 nM;TESHIGAWARA ET AL.
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FIGURE 2.
￿
IL-2-R expression by YT clone2C2cellscompared with normal activatedT cells.
Scatchard plotsof ' 251-IL-2 binding data to YT clone 2C2, before (O) andafter (0)exposure
to 20% ATL-conditioned medium for 24 h. A similarplot of humanperipheral T cell
exposure
binding after 72 h culture with anti-T3 (A) is shown for comparison. 21I-anti-Tac binding
to the YT clone 2C2 cells was negative before and after exposure to ATL-conditioned
medium. The normal T cellsexpressed 13,500 anti-Tac binding sites/cell. Molec, molecules.
20,000 sites per cell). Consequently, these data implied that this YT cell IL-2
binding site could be entirely different from the one identified using anti-Tac,
especially considering that anti-Tac does not react with the YT-2C2 cells.
Tac mRNA Expression by YT Cell Clones.
￿
An obvious but trivial explanation
for the lack of Tac antigen expression by YT-2C2 cells would be a simple point
mutation within the region encoding the Tac epitope. However, in this instance,
Tac mRNA should still be detectable. Accordingly, RNA samples from two of
the representative YT clones were extracted at intervals before and after expo-
sure to ATL-derived conditioned medium, then hybridized with a probe con-
taining the entire coding sequence for the Tac protein. Using serial dilutions of
total RNA (10-2.5 jig), quantitative analysis of densitometric scans of dot blots
proved to correlate directly with the expression of Tac antigen after exposure
to ATL-conditioned medium. Thus, ATL-conditioned medium augmented YT
clone 2137 expression of both detectable Tac mRNA (Fig. 3A) and cell surface
Tac antigen (Fig. 3B), whereas YT clone 2C2 Tac mRNA and Tac antigen
expression were undetectable before, and at every interval monitored after
exposure to ATL-conditioned medium. The actual dot blots from which the
densitometric scans were performed are presented in Fig. 3C. It is noteworthy
that YT clone 2D7 Tac mRNA expression was augmented 10-fold by ATL cell-
conditioned medium, whereas YT clone 2C2 Tac mRNA expression remained
undetectable, identical to that found with RNA from JURKAT clone 6.8, a T-
ALL cell line that does not express IL-2-11 or Tac antigen. Moreover, as shown
by the same RNA samples hybridized to a cDNA probe for HLA-B7 (Fig. 313),
equivalent amounts of mRNA from both clone 2D7 and 2C2 were analyzed at
each time interval.
To seek further substantiation that YT-2C2 cells do not express Tac mRNA,
RNA extracted from clones 2137, 2F6 and 2C2 was enriched for poly(A)+ RNA
using oligo(dT) cellulose, so as to improve the sensitivity of the hybridization
assay. As is evident in Fig. 4, even the 20-fold increase in sensitivity achieved by228
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FIC,URE 3 .
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Tac rnRNA and Tacantigen expression by Y-I' clone 2D7 and clone 2C2 before
and after exposure to ATL-conditioned medium . (A) Densitometric scans of the total RNA
dot blots shown in C andD. Hybridization was performed with the Tac 2 cDNA probe (7)
(solid symbols) and an HLA-B7 probe (18) (open symbols) . Clone 2D7 (circles) ; clone 2C2
(triangles) . Time intervals denote exposure of cells to ATL-conditioned medium . Forcompar-
ison of the hybridization intensities, the densitometric scanning results were expressed as 1 .0
arbitrary unit using Tac cDNA andJurkat 6.8 RNA. For HLA-B7 hybridization, the value
obtained with YT clone 2D7 at time 0 was assigned 1 .0 AU . (B) 1151-anti-Tac binding to clone
2D7 (0) and to clone 2C2 (A) assayedon cell aliquots at the same time intervals for A. (C) Dot
blotsof Tac cDNA hybridization to 10, 5, and 2.5 tag of total RNA from YT clone 2D7, clone
2C2,Jurkat 6.8 (negative control) and HUT-102 (positive control) . (D)The same filtersshown
in C after washingand hybridization to the HLA-B7 probe (18) .
selecting 4-5% of the total RNA failed to yield a positive signal when 2C2
poly(A)+ RNA was hybridized with Tac cDNA . By comparison, even in the
absence of exposure to ATL-conditioned medium, YT clone2D7 and clone 2F6
both contained easily detectable Tac mRNA, as did HUT-102 cells . Once again,
theJURKAT clone 6 .8 hybridization was negative and indistinguishable from
YT clone 2C2 .
Analysis ofYT Cell IL-2-binding Proteins.
￿
The only interpretation that explains
logically the expression of 2-3 X 104 IL-2 binding sites in the absence of both
cell surface Tac antigen and Tac mRNA expression predicts that the gene
product responsible for IL-2 binding by these cells should be distinct from the
Tac antigen protein . Since YT clone 2C2 cells did not react with anti-Tac, even
when immunoprecipitation experiments were attempted, the cell surface proteins
reactive with IL-2 were analyzed by forming covalent crosslinkages between ' 2'I-
IL-2 and YT clone 2C2 cells. The results from a representative experiment,
displayed in Fig . 5, reveal a single major band migrating at 90,000 M, . (p90), as
analyzed by autoradiography after SDS-PAGE (Fig . 5, lane 1) . When thechemical
crosslinking reagentwas omitted (lane 2)no crosslinkedproteins were discernible .TESHIGAWARA ET AL .
FIGURE 4.
￿
Tac mRNA expression . Dot blot hybridization of cellular poly(A)' RNA with the
Tac 2 cDNA probe (7) . Selected RNA was applied to the filters in twofold dilutions from 10
tg . HUT-102 RNA was diluted from a 20-fold lower amount (0.5 Ag) .
FIGURE 5 .
￿
SDS-PAGE ofYT clone 2C2-IL-2-binding protein as detected by "'I-IL-2 cross-
linkage . Lane 1,' 2'1-11:2 bound and crosslinked (with DSS) to YT-2C2 cells. Lane 2, DSS was
omitted . 11, X 10- ' shown at right .
229230
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￿
SDS-PAGE of IL-2-binding proteins as analyzed by 1211_IL-2 crosslinkage (A) and
by inununopredpitation with anti-Tac (B) . (A) Lane 1, control YT cells ; lane 2, YT cells
exposed to 20% ATL-conditioned medium for 24 h ; lane 3, HUT-102 cells. (B) Anti-Tac
inununoprecipitation of Y I' cells before (lane 1) and 24 h after exposure to ATL-conditioned
medium (lane 2) . ,11, . X 10- ' are shown .
Moreover, although not shown, p90 was also undetectable when a 100-fold
excess of unlabeled IL-2 was included in the binding mixture, thus providing
the appropriate IL-2 specificity control . Accordingly, the size of the YT clone
2C2 cell membrane protein calculated to be crosslinked to the 15,000M,. IL-2 is
75,000 M,. (p75), quite different from Tac antigen, which migrates at 55,000 M,.
(p55) (5) .
The results obtained with the 2C2 clone indicated that the original YT cells
should express at least two cell surface proteins capable of binding IL-2, the p55
Tac antigen and the p75 protein, both of which should be especially evident
after augmentation of Tac antigen expression via ATL-conditioned medium .
Therefore, the original YT cell line was examined for the type of IL-2-binding
proteins expressed in the presence and in the absence of exposure to ATL-
conditioned medium . As shown in Fig. 6A, in the absence of ATL-conditioned
medium, t2'I-IL-2 is crosslinked predominantly to form amembrane IL-2 com-
plex indistinguishable from the p90 observed for YT clone 2C2 cells (Fig . 6,
lane 1) . It is noteworthy that' -''I-IL-2 and 'z'I-anti-Tac bindingassays performed
on aliquots of these cells revealed 32,000 intermediate-affinity IL-2 binding sites
but only 600 high-affinity IL-2-R and 700 anti-Tac-reactive sites . For compari-
son, the SDS-PAGE pattern of YT cells exposed to ATL-conditioned medium
for 24 h before ' 2'I-IL-2 binding and crosslinking is shown in lane 2; clearly
there are two major bands visible, at 90,000 M,. and 70,000 M,-. Moreover, in
contrast to the binding studies performed on the uninduced cells, assays per-
formed on these cells yielded 6,000 high-affinity IL-2-R and 9,800 anti-Tac-
reactive sites, in addition to 25,400 intermediate-affinity IL-2 binding sites .
Using the same methods, only the 70,000 M,_ band was detectable after





SDS-PAGE of "l-11-2 crosslinked to activated normal human T cells . Lane 1, 4
nM "M L-2 bound ; lane 2, 50 pM ' 1'1-1L-2 bound . M,. X 10' are shown .
positive low-affinity IL-2 binding sites (Fig . 6, lane 3) . Accordingly, these results
are consonant with the interpretation that YT cells can express two proteins ;
one, p75, does not contain the Tac epitope, whereas the other, p55, is indistin-
guishable from Tac antigen as expressed by both normal T cells and ATL cell
lines. A final confirmation that YT cells induced by ATL-conditioned medium
express the typical Tac antigen protein is shown in Fig . 6B . The single protein,
p55, immunoprecipitated by anti-Tac is in sharp contrast to the two proteins
bound and crosslinked to 115I-IL-2 (Fig . 6A, lane 2) .
Analysis of High- and Low-Affinity Receptors Expressed by Activated Normal T
(:ells. The discovery that immature leukemic cells express an entirely new IL-
Minding protein was intriguing. However, the correlation of high-affinity
receptors with the coordinate expression of p55 and p75 implied an even more
fundamental finding: i. e., both IL-2-binding proteins may well be essential for
the formation of functional, high-affinity receptors. If so, then normal activated
T cells should also coexpress p55 and p75 . To assess this possibility, G,>/G,-
synchronized normal human T cells were activated by Pdbu, and cultured with
IL-2 for 18 h, since previous studies had established that this activation protocol
results in a ratio of 10:1 low-affinity to high-affinity IL-2 binding sites (9) . To
reveal p75, which was anticipated to be expressed in limited amounts compared
with the easily detectable amounts of p55, two different 125I-IL-2 concentrations
were used for binding before crosslinking ; a high IL-2 concentration calculated
to saturate a majority of the low-affinity binding sites, and a low IL-2 concentra-
tion that would saturate only a few low-affinity binding sites but all of the high-
affinity receptors . The results, shown in Fig . 7, are entirely consistent with those
already found for YT cells, and substantiate that high-affinity binding correlates232
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with IL-2 binding to both p75 and p55. Accordingly, as shown in Fig. 7, lane 1,
when low-affinity binding predominates, only one . ..I-IL-2-crosslinked protein
is visible at 70,000 M, . In contrast, at a low 115I-IL-2 concentration (lane 2),
which favors the proportion of high-affinity receptors relative to low-affinity
binding sites occupied, two bands emerge distinctly, M, 70,000 and 90,000 .
Discussion
Fortuitously, we have uncovered clones of a T-ALL cell line that express an
1L-2-binding protein, but do not express detectable levels of Tac mRNA nor
Tac antigen. As these cells bind IL-2 with an intermediate affinity, and the
binding protein is larger than Tac antigen, the summative evidence shows that
this novel IL-2-binding protein is encoded by a gene entirely separate from Tac.
However, even more striking is the discovery that high-affinity IL-2 binding
correlates with the dual expression of Tac antigen together with this new IL-2-
binding protein, thereby suggesting that the binding sites on both cell surface
molecules are required to cooperate to form biologically relevant, high-affinity
IL-2-R . Accordingly, to conform with the terminology of other receptor systems,
and to facilitate expression, we propose that p75 be referred to as the IL-2-R a
chain, and p55 (Tac antigen) as the IL-2-Ra chain.
Soon after the development of the IL-2 binding assay, the very first experi-
ments performed with Tac antibodies (5) revealed a large discrepancy between
the number of binding sites detectable using radiolabeled IL-2 vs. radiolabeled
anti-Tac. In particular, ATL cell lines such as HUT-102 express 50-100-fold
more anti-Tac binding sites than high-affinity IL-2-R. Subsequent experiments
defined a second class of sites that bind IL-2 with a 1000-fold lower affinity
(i . e., K,, = 10 pM vs . 10 nM) (8, 9), and the great majority (?98%) of the IL-2
binding sites expressed, especially by ATL cell lines, were found to be of the
low-affinity category . These findings became increasingly disturbing, considering
that ATL cell lines and the amino acid sequence of anti-Tac-purified protein
were used to identify cDNA clones that were purported to encode the IL-2-R
(6, 7) . After cDNA transfection experiments revealed solely low-affinity IL-2
binding by non-T cells (23, 24), but both high- and low-affinity IL-2 binding by
T cells (25, 26), it became apparent that an additional, T cell-specific protein
was necessary to form high-affinity IL-2-R . Thus far, investigators have searched
for a component that would not of itself bind IL-2, but that would serve to
convert the IL-2 binding of the Tac protein from low affinity to high affinity.
Consequently, the discovery of another IL-2-binding protein, and the evidence
that Tac antigen and this new IL-2-binding protein are coexpressed by cells that
have detectable high-affinity receptors, now make essential an entirely new
conceptual formulation of the structural basis for functional, high-affinity IL-2-
R.
Given the understanding that IL-2-R a chains and ,0 chains are coexpressed
by cells with high-affinity IL-2-R, it is somewhat puzzling that the a chain was
not discovered earlier. In retrospect, it is now easy to perceive that the large
excess of ,8 chains (10-100-fold) expressed by the only cells available for analysis
obscured the presence of the a chains. Consequently, the isolation of YT cell
clones that solely express a chains was pivotal for the present, new interpretationTESHIGAWARA ET AL.
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that two distinct IL-2-binding proteins are actually operative. Of equal impor-
tance, the ability to induce selectively the expression of (3 chains expressing Tac
antigen, while simultaneously monitoring the appearance of high-affinity IL-2-
R, made the conclusion inevitable and incontrovertable that both of these IL-2-
binding proteins must be important for the formation of high-affinity IL-2-R. In
this respect, the stoichiometry of ,8 chain expression as monitored by anti-Tac
and the expression of high-affinity receptors by YT cells stimulated with ATL-
conditioned medium is especially convincing. Moreover, this interpretation is
even more compelling when it is appreciated that either chain expressed sepa-
rately makes solely for lower affinity IL-2 binding sites.
The size of the IL-2-R a chain, being 75,000 M,-, rather than only 55,000 M,.,
provides for the expectation that the cytoplasmic domain of the a chain will be
larger than the rather short 13 residues of the ,B chain, and thus yields some
insight on possible pathways activated by IL-2-R. If the a chain contains all the
structures necessary for signal transduction, cells expressing only the a chain,
exemplified by the YT clone 2C2 cells, should respond to IL-2 . Thus far, we
have yet to detect IL-2-mediated signal transduction via the YT-2C2 a chain,
but we are mindful that these cells are neoplastic and can proliferate without IL-
2. Accordingly, additional experimental manipulations will be required to inves-
tigate fully the functional attributes of these IL-2 binding sites. Moreover, it
remains a distinct possibility that both a and ,B chains are required for detectable
signal transduction. Certainly, those cells that express only one of the chains,
such as YT-2C2 cells as reported here, or Tac cDNA transfected non-T cells
(23, 24), are unresponsive to IL-2 .
The functional role of the (3 chain also requires reconsideration in the light of
these new findings. In earlier experiments we had found that IL-2 itself induced
the expression of the fl chain (9), and others found this induction to result from
enhanced transcription (27). The IL-2-mediated transcriptional activation be-
comes manifest ultimately as a 10-fold increase in the cell surface density of Tac
antigen-positive low-affinity IL-2 binding sites (9). Concomitantly, high-affinity
IL-2-R decline by as much as 50% in the presence of IL-2 (9, 28). Our own
metabolic studies have traced the disappearance of the high-affnity IL-2-R to an
IL-2-mediated accelerated internalization of ligand-receptor complexes(Cantrell,
D. A., and K. A. Smith, manuscript in preparation). Accordingly, these obser-
vations are in harmony with the interpretation that the a chain contains the
structural information necessary for ligand-mediatedinternalization, whereas the
0 chain does not. Consistent with this view, our previous studies (9) found a very
slow turnover of Tac antigen in comparison with high-affinity IL-2-R. Therefore,
IL-2 binding to high-affinity receptors promotes rapid internalization of a chains
(and perhaps associated ,0 chains), while simultaneously, signals are generated
that result ultimately in enhanced expression of fl chain mRNA and low-affinity
cell surface binding sites. The uncertainty underlying these observations relates
to the functional importance, if any, of the expression of 10-20-fold more a
chains than a chains. Consideration of kinetic and equilibrium binding charac-
teristics of each binding site may well provide clues to this enigma, and point the
way to further experimentation.
Although the present studies indicate that a chains and # chains are expressed234
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together on the cell surface, as yet we have no data to indicate whether these
two chains associate with one another. However, it is likely that the a and ,Q
chains are linked physically, considering the effect of anti-Tac; even though the
Tac epitope is expressed only on the ,Q chain, anti-Tac prevents IL-2 binding
both to low-affinity sites and to high-affinity receptors (5, 8). In this regard, we
have recently completed an extensive study of # chains under both nonreducing
and reducing conditions, and have found that these chains form preferentially
disulfide-linked homodimers that can bind two IL-2 molecules. In contrast, a
chains expressed in the absence of 0 chains by YT clone 2C2 cells do not form
homodimers (Kato, K., and K. A. Smith, unpublished observations). The behav-
ior of these IL-2-binding proteins, especially the homodimer formation by (3
chains, is reminiscent of the behavior of the T6 and T8 glycoproteins, which are
structurally homologous members of the Ig family. On immature thymocytes T8
is found disulfide-linked to T6, whereas T8 homodimers are expressed by mature
T cells, which lack T6 molecules (29). Thus, like the Ig family, whose members
preferentially associate with themselves, or other members of the same group
(e. g., Ig H and L chains), the a and ,0 chains of the IL-2-R may well prove to
associate with one another as members of a family of homologous, but separate
and distinct lymphokine receptor molecules.
Since a chains and (3 chains bind IL-2 with distinctly different affinities (K,t =
1 nM and 10 nM, respectively), the question arises whether the same or different
sites on the IL-2 molecule interact with each binding protein. If the same
configuration on the IL-2 molecule were responsible for binding to both chains,
one would anticipate some measure of competition between the two binding
proteins, which would be evident as negative cooperation in the analysis of IL-2
binding curves. Actually, quite the opposite occurs, i. e., the expression of both
proteins is required for high-affinity IL-2 binding, thereby pointing to two
distinct active sites on the IL-2 molecule responsible for interacting separately
with each chain. This interpretation is particularly persuasive, as it hints that
high-affinity IL-2 binding sites are formed from the combination of the a and 0
chains in a manner similar to the formation of the antigen binding site from
residues contributed by both the H and L chains of Ig (30) . Particularly convinc-
ing in this regard is the finding that the chain present in limiting amounts dicates
the number of high-affinity receptors, and either a or # chains can function in
this role. For example, normal activated T cells and ATL cell lines display excess
achains as evidenced by the
121I-IL-2 crosslinking experiments, andconsequently
the number of high affinity receptors depends upon the absolute number of a
chains expressed. In contrast, YT cells express a chains in excess, and high-
affinity receptors are detected only when the cells are induced to express ,B
chains.
Theexistence of an IL-2-binding protein that does notcontain the Tac epitope
but that nonethelessappears to be necessary for the formation of fully functional
IL-2-R now calls into question the significance of finding solely Tac antigen-
positive, low-affinity IL-2 binding sites on cells other than the T cell lineage,
e. g., B cells and mast cells (31, 32). Since the a chain of the IL-2-R appears to




have a much wider tissue distribution than do high-affinity IL-2-R, it is likely
that the simultaneous expression of a chains and ,B chains is rigorously restricted
to T cells stimulated via the T cell antigen receptor complex (33). Moreover, as
IL-2 itself causes such a marked induction of0 chain expression (9) it is possible
that the a chain gene expression is triggered solely via the T cell antigen receptor
complex, whereas 0 chain expression isregulatedby the IL-2-a chain interaction.
Such a model predicts that during the T cell proliferative response to antigen,
IL-2-R a chains are expressedbefore 0 chains. Asequential activation ofa chains
followed by (3 chains is attractive, in that the IL-2-a chain-mediated induction of
(3 chains would have the effect ofpromoting formation of the more biologically
efficient high-affinity receptors, thereby lowering by 100-fold the IL-2 concen-
tration required for binding and receptor activation.
The phenotype of the YT cells, particularly of the 2C2 clone, deserves
comment, as it may well be of importance for the biologic relevance of the IL-2-
R a chain. The YT cells resemble "double negative," very immature (class I)
thymocytes (34), in thatanalysis by immunocytofluorometry usingTcell-specific
mAbs results consistently in the following pattern: T3-, T4-, T6-, T8-, T9+,
TII' (Teshigawara, K., and K. A. Smith, unpublished observations). Conse-
quently, the expression of these newly recognized IL-2 binding sites by leukemic
cells that resemble normal, immature, class I thymocytes, may well be a clue that
this binding site could play some role in normal thymocyte proliferation or
differentiation.
It is particularly noteworthy that many other polypeptide hormone receptors
are known to be present in both high-affinity and low-affinity forms (35), yet no
structural explanations for these distinct receptor classes have been uncovered.
Consequently, it is likely that the proposed model system, which involves the
generation of high-affinity IL-2-R via an interaction between two distinct low-
affinity binding proteins, will be found to reflect a general aspect of hor-
mone/receptor systems. For studies relating to T cell proliferation, the discovery
of the IL-2-R a chain is particularly timely, in that all attempts thus far to
attribute functional, high-affinity IL-2-R to the Tac protein alone have been
futile . Now, with the insight afforded by the knowledge that two IL-2-binding
proteins are involved, and that both must be expressed for the formation of
high-affinity IL-2-R, it should be possible to move forward once again to the
experimental dissection of the biochemical events triggered by IL-2-R that
initiate Tcell cycle progression.
Summary
A cell line established from a patient with acute lymphoblastic leukemia was
found to express IL-2 binding sites with a novel, intermediate affinity compared
with the characteristic high-affinity IL-2-receptors and low-affinity IL-2 binding
sites described previously. Clones were isolated from this cell line that displayed
solely this new IL-2-binding protein, and were found to be unreactive with anti-
Tac, the mAb that competes with IL-2 for binding. Moreover, these same cloned
cells did not express mRNA detectable by hybridization with radiolabeled cDNA
encoding the Tac protein. In contrast, the original cell line and similar clones
expressed low levels of Tac mRNA and cell surface Tac antigen, both of which236
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could be augmented by exposure to medium conditioned by adult T leukemia
cell lines. Particularly noteworthy, induction of Tac antigen expression was
paralleled by an increase in the number of high-affinity IL-2-R detectable. Since
the expression of the Tac antigen protein by itself makes only for low-affinity
IL-2 binding, these data prompted a reevaluation of the structural composition
of high-affinity IL-2-R. Analysis of the IL-2-binding proteins expressed by
leukemic cell lines lacking high-affinity receptors revealed only a single protein,
larger than the Tac antigen protein (M,. = 75,000 vs. 55,000). In contrast, clones
induced to express high-affinity receptors had clearly both of these IL-2-binding
proteins. Moreover, when IL-2 binding to normal T cells was performed under
conditions that favored the proportion of high-affinity receptors occupied, two
distinct proteins identical to those already identified on the leukemic cells could
be crosslinked covalently to radiolabeled IL-2. The interpretations derived from
these varied, assembled data, point to two IL-2-binding proteins, both of which
are required for high-affinity IL-2 binding.
We are grateful to Dr. J. Yodoi for the YT cell line, to Dr. E. Reinherz for the mAbs
reactive with Tac antigen, and to Dr. M. Landy for editorial comments.
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